Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?

No standard treatment has been established for metastatic uveal melanoma (mUM). Immunotherapy is commonly used for this disease even though UM has not been included in phase III clinical trials with checkpoint inhibitors. Unfortunately, only a minority of patients obtain a clinical benefit with immu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Rossi, Ernesto, Schinzari, Giovanni, Zizzari, Ilaria Grazia, Maiorano, Brigida Anna, Pagliara, Monica Maria, Sammarco, Maria Grazia, Fiorentino, Vincenzo, Petrone, Gianluigi, Cassano, Alessandra, Rindi, Guido, Bria, Emilio, Blasi, Maria Antonietta, Nuti, Marianna, Tortora, Giampaolo
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721347/
https://ncbi.nlm.nih.gov/pubmed/31357439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081055
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados